REMERON® 15 mg tablets, single dose

DRUG2 trials

Sponsors

Actavis Inc.

Conditions

Healthy

Phase 1

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions

CompletedNCT00865696

Actavis Inc.Healthy

Start: 2001-09-30End: 2001-09-30Updated: 2010-08-17

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions

CompletedNCT00865384

Actavis Inc.Healthy

Start: 2001-09-30End: 2001-09-30Updated: 2010-08-17